Dokumentdetails
ID

oai:arXiv.org:2403.18421

Thema
Computer Science - Computation and... Computer Science - Artificial Inte...
Autor
Bolton, Elliot Venigalla, Abhinav Yasunaga, Michihiro Hall, David Xiong, Betty Lee, Tony Daneshjou, Roxana Frankle, Jonathan Liang, Percy Carbin, Michael Manning, Christopher D.
Kategorie

Computer Science

Jahr

2024

Auflistungsdatum

03.04.2024

Schlüsselwörter
trained models
Metrisch

Zusammenfassung

Models such as GPT-4 and Med-PaLM 2 have demonstrated impressive performance on a wide variety of biomedical NLP tasks.

However, these models have hundreds of billions of parameters, are computationally expensive to run, require users to send their input data over the internet, and are trained on unknown data sources.

Can smaller, more targeted models compete?

To address this question, we build and release BioMedLM, a 2.7 billion parameter GPT-style autoregressive model trained exclusively on PubMed abstracts and full articles.

When fine-tuned, BioMedLM can produce strong multiple-choice biomedical question-answering results competitive with much larger models, such as achieving a score of 57.3% on MedMCQA (dev) and 69.0% on the MMLU Medical Genetics exam.

BioMedLM can also be fine-tuned to produce useful answers to patient questions on medical topics.

This demonstrates that smaller models can potentially serve as transparent, privacy-preserving, economical and environmentally friendly foundations for particular NLP applications, such as in biomedicine.

The model is available on the Hugging Face Hub: https://huggingface.co/stanford-crfm/BioMedLM.

;Comment: 23 pages

Bolton, Elliot,Venigalla, Abhinav,Yasunaga, Michihiro,Hall, David,Xiong, Betty,Lee, Tony,Daneshjou, Roxana,Frankle, Jonathan,Liang, Percy,Carbin, Michael,Manning, Christopher D., 2024, BioMedLM: A 2.7B Parameter Language Model Trained On Biomedical Text

Dokumentieren

Öffnen

Teilen

Quelle

Artikel empfohlen von ES/IODE AI

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
agphd1 subtypes replication hykk squamous cell gene carcinoma causal targets mendelian randomization cancer analysis